Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
Anti-melanoma differentiation-associated protein 5 (anti-MDA5) associated clinically amyopathic dermatomyositis (CADM) is an extremely rare disease associated with significantly higher morbidity and mortality compared to other inflammatory myopathies.This report describes a unique case of a patient who presented with an acute interstitial pneumonia and rapidly progressing respiratory failure due to an undiagnosed anti-MDA5 amyopathic dermatomyositis, without any of the typical dermatomyositis symptoms or physical exam findings.Diagnosis of anti-MDA5 amyopathic dermatomyositis is challenging and standardized treatments for this disease have not been fully developed, which highlights the importance of multidisciplinary approach and collaboration between medical centres.
Authors
- Inita Buliņa
- Kristīne Ivanova (ORCID: https://orcid.org/0000-0003-2127-2948)
- Zaiga Kravale (ORCID: https://orcid.org/0000-0003-0571-1437)
- Dace Žentiņa (ORCID: https://orcid.org/0000-0002-5148-7010)
- Darija Logvinova
Institutions
- Pauls Stradiņš Clinical University Hospital (LV)
- Riga Stradiņš University (LV)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2024-11-29
- DOI
- https://doi.org/10.12890/2024_005036
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00